DK1523572T3 - Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination - Google Patents
Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk disseminationInfo
- Publication number
- DK1523572T3 DK1523572T3 DK03762684T DK03762684T DK1523572T3 DK 1523572 T3 DK1523572 T3 DK 1523572T3 DK 03762684 T DK03762684 T DK 03762684T DK 03762684 T DK03762684 T DK 03762684T DK 1523572 T3 DK1523572 T3 DK 1523572T3
- Authority
- DK
- Denmark
- Prior art keywords
- targets
- prevention
- control
- bacterial infections
- serum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0208636A FR2842210B1 (fr) | 2002-07-09 | 2002-07-09 | Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique |
PCT/EP2003/008209 WO2004005535A2 (en) | 2002-07-09 | 2003-07-09 | Pathogenicity proteins which can be used as targets for developing means for preventing and controlling bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1523572T3 true DK1523572T3 (da) | 2008-09-08 |
Family
ID=29763685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03762684T DK1523572T3 (da) | 2002-07-09 | 2003-07-09 | Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination |
Country Status (12)
Country | Link |
---|---|
US (3) | US20060003393A1 (da) |
EP (1) | EP1523572B1 (da) |
JP (1) | JP2006515155A (da) |
AT (1) | ATE394503T1 (da) |
AU (2) | AU2003266246A1 (da) |
CA (1) | CA2491847A1 (da) |
DE (1) | DE60320797D1 (da) |
DK (1) | DK1523572T3 (da) |
ES (1) | ES2306891T3 (da) |
FR (1) | FR2842210B1 (da) |
HK (1) | HK1078902A1 (da) |
WO (1) | WO2004005535A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2842210B1 (fr) * | 2002-07-09 | 2012-12-14 | Mutabilis | Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique |
WO2004050846A2 (en) * | 2002-12-02 | 2004-06-17 | Biosynexus Incorporated | Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
HUE027400T2 (en) | 2005-02-18 | 2016-10-28 | Glaxosmithkline Biologicals Sa | Proteins and nucleic acids from meningitis / sepsis with Escherichia coli |
ES2385045T3 (es) | 2005-02-18 | 2012-07-17 | Novartis Vaccines And Diagnostics, Inc. | Inmunógenos de Escherichia coli uropatogénica |
EP1973467B1 (en) * | 2006-01-20 | 2013-10-16 | The General Hospital Corporation | Systems and process for providing speckle reduction using a wave front modulation for optical coherence tomography |
EP2586790A3 (en) | 2006-08-16 | 2013-08-14 | Novartis AG | Immunogens from uropathogenic Escherichia coli |
SG178035A1 (en) | 2009-07-16 | 2012-03-29 | Novartis Ag | Detoxified escherichia coli immunogens |
US20190161785A1 (en) * | 2016-04-25 | 2019-05-30 | Aperture Bio, LLC | Systems, Devices and Methods for Sequential Analysis of Complex Matrix Samples for High Confidence Bacterial Detection and Drug Susceptibility Prediction Using a Flow Cytometer |
JP7515092B2 (ja) * | 2017-10-18 | 2024-07-12 | 北海道公立大学法人 札幌医科大学 | 抗菌剤のスクリーニング方法 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
CN115725607B (zh) * | 2022-07-14 | 2023-11-28 | 山东第一医科大学附属省立医院(山东省立医院) | 一种鼻疽诺卡菌的致病靶基因及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020121A (en) * | 1995-09-29 | 2000-02-01 | Microcide Pharmaceuticals, Inc. | Inhibitors of regulatory pathways |
CA2330544A1 (en) * | 1998-06-12 | 1999-12-23 | University Of Guelph | A novel gene and method of treating a gram negative bacterial infection |
DE69937965T2 (de) * | 1998-11-09 | 2009-01-08 | Microscience Ltd., Wokingham | Virulenzgene und -proteine und deren Verwendung |
JP2002535007A (ja) * | 1999-01-27 | 2002-10-22 | エリトラ ファーマシューティカルズ,インコーポレイテッド | Escherichiacoliの増殖に必要であると同定された遺伝子 |
FR2842210B1 (fr) * | 2002-07-09 | 2012-12-14 | Mutabilis | Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique |
-
2002
- 2002-07-09 FR FR0208636A patent/FR2842210B1/fr not_active Expired - Lifetime
-
2003
- 2003-07-09 CA CA002491847A patent/CA2491847A1/en not_active Abandoned
- 2003-07-09 ES ES03762684T patent/ES2306891T3/es not_active Expired - Lifetime
- 2003-07-09 WO PCT/EP2003/008209 patent/WO2004005535A2/en active IP Right Grant
- 2003-07-09 AU AU2003266246A patent/AU2003266246A1/en not_active Abandoned
- 2003-07-09 DK DK03762684T patent/DK1523572T3/da active
- 2003-07-09 DE DE60320797T patent/DE60320797D1/de not_active Expired - Lifetime
- 2003-07-09 EP EP03762684A patent/EP1523572B1/en not_active Expired - Lifetime
- 2003-07-09 AT AT03762684T patent/ATE394503T1/de active
- 2003-07-09 JP JP2004518773A patent/JP2006515155A/ja active Pending
- 2003-07-09 US US10/520,820 patent/US20060003393A1/en not_active Abandoned
-
2005
- 2005-10-20 HK HK05109367A patent/HK1078902A1/xx not_active IP Right Cessation
-
2006
- 2006-08-21 US US11/506,821 patent/US20070111229A1/en not_active Abandoned
-
2009
- 2009-04-30 AU AU2009201727A patent/AU2009201727A1/en not_active Abandoned
-
2010
- 2010-03-23 US US12/729,630 patent/US20110236886A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070111229A1 (en) | 2007-05-17 |
US20110236886A1 (en) | 2011-09-29 |
HK1078902A1 (en) | 2006-03-24 |
AU2009201727A1 (en) | 2009-05-21 |
ES2306891T3 (es) | 2008-11-16 |
WO2004005535A3 (en) | 2004-11-18 |
WO2004005535A2 (en) | 2004-01-15 |
EP1523572B1 (en) | 2008-05-07 |
FR2842210B1 (fr) | 2012-12-14 |
US20060003393A1 (en) | 2006-01-05 |
EP1523572A2 (en) | 2005-04-20 |
CA2491847A1 (en) | 2004-01-15 |
ATE394503T1 (de) | 2008-05-15 |
FR2842210A1 (fr) | 2004-01-16 |
AU2003266246A1 (en) | 2004-01-23 |
DE60320797D1 (de) | 2008-06-19 |
JP2006515155A (ja) | 2006-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1078902A1 (en) | Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination | |
Nanda et al. | Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions | |
Ushijima et al. | Vibrio coralliilyticus strain OCN008 is an etiological agent of acute Montipora white syndrome | |
Burley et al. | CRISPR-Cas, a prokaryotic adaptive immune system, in endodontic, oral, and multidrug-resistant hospital-acquired Enterococcus faecalis | |
Connolly et al. | The host metabolite D-serine contributes to bacterial niche specificity through gene selection | |
Park et al. | Development of multiplex PCR assay for simultaneous detection of Salmonella genus, Salmonella subspecies I, Salm. Enteritidis, Salm. Heidelberg and Salm. Typhimurium | |
Jeong et al. | Draft genome sequence of the plant growth-promoting bacterium Bacillus siamensis KCTC 13613T | |
Hutcherson et al. | Comparison of inherently essential genes of Porphyromonas gingivalis identified in two transposon‐sequencing libraries | |
Brüggemann et al. | Genomics of Clostridium tetani | |
ATE438731T1 (de) | Verfahren zur herstellung einer l-aminosäure unter verwendung eines bakteriums der familie enterobacteriaceae | |
Minnick et al. | Developmental biology of Coxiella burnetii | |
Yogurtcu et al. | Antibiotic susceptibility patterns of E nterococcus strains isolated from T urkish T ulum cheese | |
Armin et al. | Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture | |
MX356959B (es) | Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos. | |
Gualtieri et al. | Draft genome sequence and annotation of the entomopathogenic bacterium Xenorhabdus szentirmaii strain DSM16338 | |
Ohnishi et al. | Genome sequence of a Bacillus anthracis outbreak strain from Zambia, 2011 | |
DK1504088T3 (da) | Bakteriofager egnede til behandling og forebyggelse af bakterielle infektioner | |
Tabata et al. | A streptolysin S homologue is essential for β-haemolytic Streptococcus constellatus subsp. constellatus cytotoxicity | |
Sangal et al. | Genomic analyses confirm close relatedness between Rhodococcus defluvii and Rhodococcus equi (Rhodococcus hoagii) | |
Ang et al. | Genome sequence of Parvimonas micra strain A293, isolated from an abdominal abscess from a patient in the United Kingdom | |
ATE523596T1 (de) | Verfahren zur herstellung von polyhydroxyalkanoat | |
EP3932416A4 (en) | COMPOSITION FOR IMPROVEMENT, PREVENTION OR TREATMENT OF BONE DISEASES OR METABOLIC DISEASES, INCLUDING NEW LACTOBACILLUS SAKEI CVL-001 STRAIN AND CULTURE MEDIUM THEREOF | |
Krueger et al. | Unravelling post‐transcriptional PrmC‐dependent regulatory mechanisms in Pseudomonas aeruginosa | |
Sturm et al. | Draft genome sequence of Leucobacter chromiiresistens, an extremely chromium-tolerant strain | |
Paixão et al. | Genotypic characterization of Yersinia enterocolitica biotype 4/O: 3 isolates from pigs and slaughterhouses using SE‐AFLP, ERIC‐PCR, and PFGE |